SAPS2 Inhibitors
SAPS2 inhibitors are compounds that specifically target and modulate the activity of the SAPS2 (SIT4-Associated Protein, homolog 2) domain, a regulatory subunit of certain protein phosphatases involved in various cellular processes. SAPS2 is associated with the PP6 protein phosphatase complex, a highly conserved enzyme complex that regulates multiple intracellular signaling pathways, including those related to cellular proliferation, DNA repair, and stress responses. SAPS2 plays a crucial role in directing the specificity and localization of the PP6 catalytic subunit, thereby influencing its interaction with substrates and other regulatory molecules. Inhibitors of SAPS2 interfere with this regulatory function, leading to the modulation of the enzymatic activity of PP6. By preventing the interaction between SAPS2 and PP6, these inhibitors alter key processes related to protein dephosphorylation, thus impacting various biochemical pathways dependent on phosphatase activity.
From a molecular standpoint, SAPS2 inhibitors are often characterized by their ability to bind specifically to the SAPS2 domain, disrupting its structure or its interaction with the catalytic subunit of the PP6 complex. This binding is typically non-covalent and reversible, although some compounds may exhibit higher affinity and more prolonged inhibition through additional molecular interactions. The structural diversity of these inhibitors can vary greatly, with some being small molecules that fit into the binding site of SAPS2, while others may be larger molecules that sterically hinder protein-protein interactions. The inhibition of SAPS2 often leads to altered phosphorylation states of various substrates, potentially affecting key processes such as cell cycle regulation and protein stability. The study of these inhibitors is significant for understanding the biochemical and regulatory roles of protein phosphatases in various cellular mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may downregulate SAPS2 expression by inhibiting histone deacetylase, which could lead to a more open chromatin state at the SAPS2 promoter, facilitating the acetylation of histone proteins and a decrease in transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor may decrease the methylation levels of the SAPS2 gene promoter, potentially reducing its transcriptional activity and leading to lower SAPS2 protein synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin could disrupt the downstream signaling required for cell cycle progression, which may result in the downregulation of the SAPS2 gene due to altered demand for its regulatory function in mitosis. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may decrease the expression of SAPS2 by inhibiting histone deacetylases, contributing to epigenetic modifications that lead to a compact chromatin structure and reduced accessibility of the SAPS2 gene to transcription factors. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
By stabilizing microtubules and inhibiting the normal function of the mitotic spindle, Taxol may disrupt the cell cycle and indirectly lead to the downregulation of SAPS2, whose regulatory function is no longer required at the same levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
As a proteasome inhibitor, bortezomib may lead to decreased SAPS2 protein levels by causing the accumulation of ubiquitinated proteins, which can trigger cellular stress responses that include the downregulation of various genes, potentially including SAPS2. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
By preventing the degradation of p53, Nutlin-3 may initiate a cascade of gene expression changes favoring cell cycle arrest, which could include the downregulation of SAPS2 expression as part of the cellular response to stress. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
By blocking peptide elongation during protein synthesis, cycloheximide can lead to a general decrease in protein levels, including a reduction in the synthesis of SAPS2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits the PI3K pathway, which may lead to a reduction in the phosphorylation and activation of downstream targets, potentially resulting in the decreased expression of SAPS2 due to reduced cellular proliferation signals. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog can reduce cellular energy production by inhibiting glycolysis, which might lead to a general decrease in the biosynthetic capacity of the cell, including the synthesis of SAPS2. | ||||||